Salicylic acid

Description

Ximiannaoi is identified by the SPL Code 34089-3. It is presented in a media type of image/jpeg.

Uses and Indications

This drug is indicated for the treatment of acne. It functions by drying up existing acne lesions and helps prevent the formation of new acne.

There are no teratogenic or nonteratogenic effects associated with this drug as per the available data.

Dosage and Administration

The recommended dosage is to apply the medication once daily. In cases where bothersome dryness or peeling occurs, the application frequency should be reduced to every other day. It is important for healthcare professionals to monitor the patient's response to treatment and adjust the application schedule as necessary to ensure optimal tolerability and effectiveness.

Contraindications

Use of this product is contraindicated in the following situations:

Application on broken skin is prohibited due to the potential for increased irritation and adverse effects. Additionally, the product should not be used during pregnancy or lactation, as safety has not been established in these populations.

It is also advised to avoid contact with the eyes, as this may lead to significant discomfort or injury. Concurrent use with other topical acne medications may exacerbate dryness or skin irritation, and therefore, such combinations should be avoided.

Warnings and Precautions

For external use only. This product is contraindicated for application on broken skin. Healthcare professionals should advise patients who are pregnant or lactating to refrain from using this product due to potential risks.

In the event of accidental ingestion, it is imperative to seek emergency medical assistance or contact a Poison Control Center immediately.

Patients should be instructed to discontinue use and consult a healthcare provider if they experience excessive skin irritation or increased sensitivity. Monitoring for these adverse reactions is essential to ensure patient safety and well-being.

Side Effects

For external use only. Patients are advised to discontinue use and consult a healthcare professional if they experience excessive skin irritation or sensitivity that develops or increases. It is important for participants to monitor their skin's response to the product and seek medical advice if adverse reactions occur.

Drug Interactions

Concurrent use of other topical acne medications may lead to increased dryness or skin irritation. It is advisable to monitor the skin condition closely when combining treatments. If excessive dryness or irritation occurs, dosage adjustments or a reevaluation of the treatment regimen may be necessary to mitigate these effects.

Packaging & NDC

Below are the non-prescription pack sizes of Salicylic Acid Acne Removal Cleanser. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep the medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are lactating should not use this medication. The potential risks associated with the use of this drug during pregnancy have not been established, and its safety profile in this population remains unclear. Healthcare professionals are advised to consider alternative treatment options for women who are pregnant or breastfeeding to avoid any potential adverse effects on fetal outcomes or infant health.

Lactation

Lactating mothers are advised against the use of this medication. There is insufficient data regarding the excretion of the drug in human breast milk and its effects on breastfed infants. Therefore, caution is warranted, and alternative treatments should be considered for lactating individuals.

Renal Impairment

Patients with renal impairment may necessitate dosage adjustments based on their level of kidney function. It is important for healthcare professionals to monitor the creatinine clearance in patients with reduced renal function to ensure appropriate dosing. Additionally, special monitoring of renal function tests is recommended for patients with existing kidney problems to mitigate potential risks associated with medication use.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, the following management procedures should be considered:

1. Assessment: Conduct a thorough assessment of the patient's clinical status, including vital signs and level of consciousness.

2. Supportive Care: Provide supportive care as needed, which may include airway management, oxygen supplementation, and intravenous fluids.

3. Consultation: Engage with a poison control center or a medical toxicologist for guidance on specific interventions and antidotes, if applicable.

4. Documentation: Document all findings, interventions, and the patient's response to treatment meticulously.

Healthcare professionals should remain vigilant and prepared to implement these general management strategies in the event of an overdose, despite the lack of specific information regarding the substance in question.

Nonclinical Toxicology

The use of this product is contraindicated in pregnant or lactating individuals due to potential teratogenic effects. No non-teratogenic effects have been specified in the available data. Additionally, there are no details provided regarding nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available in the provided text.

Patient Counseling

Patients should be advised to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients that the product should not be applied to broken skin and is not recommended for use during pregnancy or lactation.

Healthcare providers should counsel patients to discontinue use and consult a doctor if they experience excessive skin irritation or sensitivity that develops or worsens. Patients should also be instructed to avoid unnecessary sun exposure while using the product and to apply a sunscreen to protect their skin.

Additionally, patients must be cautioned against using the product in or near the eyes. It is essential to inform them that concurrent use of other topical acne medications may lead to increased dryness or skin irritation, and they should be advised to avoid such combinations unless directed by a healthcare professional.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which are essential for identification and inventory management. It is recommended to store the product at room temperature, ensuring that it is protected from excessive heat to maintain its integrity. The container should be kept tightly closed when not in use to prevent contamination and degradation. Additionally, it is important to discard the product after opening to ensure safety and efficacy.

Additional Clinical Information

The medication is administered topically and is recommended for once-daily use. In cases where patients experience bothersome dryness or peeling, the application frequency should be reduced to every other day.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Salicylic Acid Acne Removal Cleanser, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)